HER-2 as a target for breast cancer therapy.

Subjects

Subjects :

Antibodies, Monoclonal adverse effects
Antibodies, Monoclonal, Humanized
Breast Neoplasms chemistry
Female
Humans
Receptor, ErbB-2 analysis
Receptor, ErbB-2 physiology
Trastuzumab
Antibodies, Monoclonal therapeutic use
Breast Neoplasms drug therapy
Receptor, ErbB-2 antagonists & inhibitors

Details

Language :

English

ISSN :

1078-0432

Volume :

15

Issue :

6

Database :

MEDLINE

Journal :

Clinical cancer research : an official journal of the American Association for Cancer Research

Publication Type :

Academic Journal

Accession number :

19289395

Full Text :

https://doi.org/10.1158/1078-0432.CCR-08-1844